Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study
Robin Schaefer(World Health Organization), Shona Dalal(World Health Organization), Daniel Low‐Beer(World Health Organization), Naoko Ishikawa(World Health Organization Regional Office for the Western Pacific), Nabeel Mangadan Konath(World Health Organization Regional Office for South-East Asia), H Schmidt(Joint United Nations Programme on HIV/AIDS), Boniface Dongmo Nguimfack(World Health Organization), Joumana Hermez(World Health Organization Regional Office for the Eastern Mediterranean), Anne Brink(World Health Organization Regional Office for the Western Pacific), Ahmed Sabry Alaama(World Health Organization Regional Office for the Eastern Mediterranean), Giovanni Ravasi(European Centre for Disease Prevention and Control), Antons Mozalevskis(World Health Organization), Frank Lule(World Health Organization Regional Office for Africa), Rachel Baggaley(World Health Organization), Bharat Bhushan Rewari(National AIDS Control Organisation), Kouadio Yeboue(West African Health Organisation), Nicole Seguy(World Health Organization Regional Office for Europe), Mukta Sharma(Children's Mercy Hospital)
Cited by 112
Related Papers
Estimates of the global burden of cervical cancer associated with HIV
|The Lancet Global Health|2020|912
Non-communicable diseases in sub-Saharan Africa: what we know now
|International Journal of Epidemiology|2011|651
Requirements for global elimination of hepatitis B: a modelling study
|The Lancet Infectious Diseases|2016|384
Global reporting of progress towards elimination of hepatitis B and hepatitis C
|The Lancet. Gastroenterology & hepatology|2023|323